STRENGTH UNIT: BALANCE & RUN UNIT
Sign up via the official LIC 2026 app.

Networking Breakfast at the hotel

Welcome to LIC 2026!

Welcome address from Daniel Koetser

Dr. Aubrey de Grey, Natalie Coles, and Dr. Tobias Reichmuth examine why supercentenarians could unlock the next wave of longevity breakthroughs. Investors will hear why funding supercentenarian research might yield outsized returns in both health impact and economic opportunity.

This session doesn't debate the science of longevity — it debates the delivery of it. Four practitioners who represent four genuinely different philosophies on how aging should be treated: rigorous academic geroscience that targets aging as a disease, elite concierge medicine that wraps science in extreme personalization, experimental regenerative medicine that operates at the frontier of what's proven, and academic hospital longevity medicine that bridges research and clinical practice.

For investors, the question is not which model is most scientifically compelling. It's which model is scalable, fundable, and defensible — and where the overlaps create the most interesting opportunities.

The longevity investment boom has produced remarkable science - and an enormous amount of noise. At LIC 2026, the man who invented the epigenetic clock and an associate director from inside Novartis's diseases of aging program sit down with one agenda: to tell investors the actual criteria they use to separate rigorous aging science from a compelling pitch deck. What counts as real evidence. What a validated and druggable target actually looks like. What questions should end a conversation before the term sheet stage.

Exceptional Ventures is a London-based business with a mission to help as many people around the globe live longer, healthier, and happier lives, maximising what we call Joyspan®. At our core is a science-driven venture capital firm investing in early-stage companies driving the current revolution in human health.

Founded in 2022 by Matt Cooper and Paolo Pio, EV brings decades of entrepreneurial, operating and investment expertise across Prevention, Early Detection & Risk Assessment, and Smarter Treatment & Care Delivery. We partner with the very best founders and scientists. We are building a virtuous cycle of support from academics, researchers and policy makers to help them make the giant leaps forward in the way we treat and understand human health.


The session will declare that we all have a choice in how we shape our future. That we all need to take a stand to move the world.

People are living longer, healthier lives, fundamentally changing how wealth should be created, managed and transferred. This session explores how portfolio construction, intergenerational wealth planning and investment opportunities will evolve in response to increased longevity. We will examine practical strategies for managing portfolios over extended time horizons while highlighting the sectors best positioned to benefit from one of the most significant demographic shifts of our time.

Plenty of companies are built for the next funding round. Far fewer are built to still be leading the field thirty years from now. This session asks the harder, less fashionable question: what does it actually take to build a longevity enterprise that stays standing, stays scientifically credible, and keeps leading — decade after decade, not just cycle after cycle?
Four people who sit at different points of the build-and-fund lifecycle — early-stage investing, growth-stage strategy, science-to-product translation, and the operating reality of running a longevity company at scale today — talk candidly about what "sustainable" really means in an industry that moves between hype cycles every eighteen months.

Dave Asprey: What Actually Works: Separating Signal from Noise in Longevity
Dr. Adeel Khan & Max Marchione: Peptides in Longevity: Hype, Evidence & Investment Reality
Jordan Shlain, MD: From Silicon Valley - Emerging Technology

A private sunset reception, a three-minute stroll from Le Grand Bellevue. The MANSARD rooftop opens to panoramic views of Gstaad and the Promenade - an elegant setting for high-value conversations before dinner.